Guidance

National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine

This protocol is for the administration of Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine to children aged 5 to 11 years in accordance with the national COVID-19 vaccination programme.

• From: UK Health Security Agency
• Published: 24 January 2022
• Last updated: 14 December 2022 — See all updates

This publication was withdrawn on 6 April 2023

This protocol has been superseded by the COVID-19 adult and children 5 to 17 years national protocols.

Applies to England

Documents

[Withdrawn] National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine

Ref: UKHSA gateway number GOV-13454

MS Word Document, 246 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of Comirnaty® 10 microgram/dose concentrate for dispersion for injection COVID-19 mRNA vaccine to children aged 5 to 11 years by appropriately trained persons.

National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine v05.00 is valid from 13 December 2022 to 14 December 2023.

Published 24 January 2022

Last updated 14 December 2022 + show all updates

1. 14 December 2022

   Added latest version – details of changes on page 4.

2. 7 September 2022

   Added version 03.00 – details of changes on page 3.

3. 1 April 2022

   Removed expired protocol (v01.00).

4. 25 March 2022

   Added version 02.00 – details of changes on page 3.

5. 24 January 2022

   First published.